HEADER TRANSFERASE 03-MAR-15 4YJT TITLE THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH TITLE 2 GTC000233 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE SYK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 355-635; COMPND 5 SYNONYM: SPLEEN TYROSINE KINASE,P72-SYK; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SYK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9 KEYWDS SYK, NON-RECEPTOR TYROSINE KINASE, SPLEEN TYROSINE KINASE, KEYWDS 2 TRANSFERASE, PHOSPHORYLATION, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 3 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.O.SOMERS,M.NEU,J.STUCKEY REVDAT 3 13-NOV-24 4YJT 1 REMARK REVDAT 2 01-MAY-24 4YJT 1 REMARK REVDAT 1 30-SEP-15 4YJT 0 JRNL AUTH J.LIDDLE,F.L.ATKINSON,M.D.BARKER,P.S.CARTER,N.R.CURTIS, JRNL AUTH 2 R.P.DAVIS,C.DOUAULT,M.C.DICKSON,D.ELWES,N.S.GARTON,M.GRAY, JRNL AUTH 3 T.G.HAYHOW,C.I.HOBBS,E.JONES,S.LEACH,K.LEAVENS,H.D.LEWIS, JRNL AUTH 4 S.MCCLEARY,M.NEU,V.K.PATEL,A.G.PRESTON,C.RAMIREZ-MOLINA, JRNL AUTH 5 T.J.SHIPLEY,P.A.SKONE,N.SMITHERS,D.O.SOMERS,A.L.WALKER, JRNL AUTH 6 R.J.WATSON,G.G.WEINGARTEN JRNL TITL DISCOVERY OF GSK143, A HIGHLY POTENT, SELECTIVE AND ORALLY JRNL TITL 2 EFFICACIOUS SPLEEN TYROSINE KINASE INHIBITOR. JRNL REF BIOORG. MED. CHEM. LETT. V. 21 6188 2011 JRNL REFN ESSN 1464-3405 JRNL PMID 21903390 JRNL DOI 10.1016/J.BMCL.2011.07.082 REMARK 2 REMARK 2 RESOLUTION. 1.52 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.52 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.53 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 41545 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 2075 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.52 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.56 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.82 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3047 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2113 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2901 REMARK 3 BIN R VALUE (WORKING SET) : 0.2100 REMARK 3 BIN FREE R VALUE : 0.2371 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.79 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 146 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2198 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 315 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.74 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.51 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.71750 REMARK 3 B22 (A**2) : 0.71510 REMARK 3 B33 (A**2) : 1.00250 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.46240 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.169 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.079 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.081 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.076 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.079 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.952 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2357 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3207 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1087 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 59 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 337 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2357 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 271 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3022 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.02 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.95 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.66 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: {A|*} REMARK 3 ORIGIN FOR THE GROUP (A): 33.3830 27.7204 36.2076 REMARK 3 T TENSOR REMARK 3 T11: -0.0288 T22: -0.0315 REMARK 3 T33: -0.0387 T12: -0.0106 REMARK 3 T13: 0.0065 T23: -0.0240 REMARK 3 L TENSOR REMARK 3 L11: 0.5263 L22: 0.8150 REMARK 3 L33: 0.6582 L12: -0.4008 REMARK 3 L13: 0.1186 L23: -0.1213 REMARK 3 S TENSOR REMARK 3 S11: -0.0024 S12: 0.0313 S13: -0.0328 REMARK 3 S21: 0.0221 S22: -0.0318 S23: -0.0576 REMARK 3 S31: -0.0380 S32: 0.0179 S33: 0.0342 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4YJT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-MAR-15. REMARK 100 THE DEPOSITION ID IS D_1000207405. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-APR-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM 6.2.4 REMARK 200 DATA SCALING SOFTWARE : SCALA 3.2.5 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48894 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.440 REMARK 200 RESOLUTION RANGE LOW (A) : 27.535 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.05500 REMARK 200 R SYM (I) : 0.05500 REMARK 200 FOR THE DATA SET : 13.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.44 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.52 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.50100 REMARK 200 R SYM FOR SHELL (I) : 0.50100 REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: IN-HOUSE SYK MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% JEFFAMINE ED-2001, 10% GLYCEROL, REMARK 280 0.1M MES PH6.0, 5MM TCEP, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 43.60700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 210 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13790 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 ILE A 358 REMARK 465 ARG A 359 REMARK 465 PRO A 360 REMARK 465 LYS A 361 REMARK 465 GLU A 362 REMARK 465 VAL A 363 REMARK 465 VAL A 634 REMARK 465 ASN A 635 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 381 CG OD1 ND2 REMARK 470 LYS A 393 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLN A 391 O HOH A 801 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 MET A 448 SD MET A 448 CE -0.379 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 394 -54.11 -135.23 REMARK 500 ALA A 441 -122.45 -143.19 REMARK 500 ASP A 494 43.19 -151.44 REMARK 500 ASP A 512 73.99 58.96 REMARK 500 TRP A 609 33.77 -90.90 REMARK 500 ASN A 628 43.52 -106.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1111 DISTANCE = 5.93 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4DQ A 702 DBREF 4YJT A 355 635 UNP P43405 KSYK_HUMAN 355 635 SEQRES 1 A 281 PRO GLU GLU ILE ARG PRO LYS GLU VAL TYR LEU ASP ARG SEQRES 2 A 281 LYS LEU LEU THR LEU GLU ASP LYS GLU LEU GLY SER GLY SEQRES 3 A 281 ASN PHE GLY THR VAL LYS LYS GLY TYR TYR GLN MET LYS SEQRES 4 A 281 LYS VAL VAL LYS THR VAL ALA VAL LYS ILE LEU LYS ASN SEQRES 5 A 281 GLU ALA ASN ASP PRO ALA LEU LYS ASP GLU LEU LEU ALA SEQRES 6 A 281 GLU ALA ASN VAL MET GLN GLN LEU ASP ASN PRO TYR ILE SEQRES 7 A 281 VAL ARG MET ILE GLY ILE CYS GLU ALA GLU SER TRP MET SEQRES 8 A 281 LEU VAL MET GLU MET ALA GLU LEU GLY PRO LEU ASN LYS SEQRES 9 A 281 TYR LEU GLN GLN ASN ARG HIS VAL LYS ASP LYS ASN ILE SEQRES 10 A 281 ILE GLU LEU VAL HIS GLN VAL SER MET GLY MET LYS TYR SEQRES 11 A 281 LEU GLU GLU SER ASN PHE VAL HIS ARG ASP LEU ALA ALA SEQRES 12 A 281 ARG ASN VAL LEU LEU VAL THR GLN HIS TYR ALA LYS ILE SEQRES 13 A 281 SER ASP PHE GLY LEU SER LYS ALA LEU ARG ALA ASP GLU SEQRES 14 A 281 ASN PTR PTR LYS ALA GLN THR HIS GLY LYS TRP PRO VAL SEQRES 15 A 281 LYS TRP TYR ALA PRO GLU CYS ILE ASN TYR TYR LYS PHE SEQRES 16 A 281 SER SER LYS SER ASP VAL TRP SER PHE GLY VAL LEU MET SEQRES 17 A 281 TRP GLU ALA PHE SER TYR GLY GLN LYS PRO TYR ARG GLY SEQRES 18 A 281 MET LYS GLY SER GLU VAL THR ALA MET LEU GLU LYS GLY SEQRES 19 A 281 GLU ARG MET GLY CYS PRO ALA GLY CYS PRO ARG GLU MET SEQRES 20 A 281 TYR ASP LEU MET ASN LEU CYS TRP THR TYR ASP VAL GLU SEQRES 21 A 281 ASN ARG PRO GLY PHE ALA ALA VAL GLU LEU ARG LEU ARG SEQRES 22 A 281 ASN TYR TYR TYR ASP VAL VAL ASN MODRES 4YJT PTR A 525 TYR MODIFIED RESIDUE MODRES 4YJT PTR A 526 TYR MODIFIED RESIDUE HET PTR A 525 16 HET PTR A 526 16 HET GOL A 701 6 HET 4DQ A 702 49 HETNAM PTR O-PHOSPHOTYROSINE HETNAM GOL GLYCEROL HETNAM 4DQ N~2~-(1,1-DIOXIDO-2,3-DIHYDRO-1,2-BENZOTHIAZOL-6-YL)- HETNAM 2 4DQ N~4~-ETHYL-5-FLUORO-N~4~-(1H-INDAZOL-4-YL)PYRIMIDINE- HETNAM 3 4DQ 2,4-DIAMINE HETSYN PTR PHOSPHONOTYROSINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 2 GOL C3 H8 O3 FORMUL 3 4DQ C20 H18 F N7 O2 S FORMUL 4 HOH *315(H2 O) HELIX 1 AA1 ASP A 366 LYS A 368 5 3 HELIX 2 AA2 ASN A 406 ASN A 409 5 4 HELIX 3 AA3 ASP A 410 GLN A 425 1 16 HELIX 4 AA4 LEU A 456 ASN A 463 1 8 HELIX 5 AA5 LYS A 467 SER A 488 1 22 HELIX 6 AA6 ALA A 496 ARG A 498 5 3 HELIX 7 AA7 PRO A 535 TYR A 539 5 5 HELIX 8 AA8 ALA A 540 TYR A 547 1 8 HELIX 9 AA9 SER A 551 SER A 567 1 17 HELIX 10 AB1 LYS A 577 LYS A 587 1 11 HELIX 11 AB2 PRO A 598 TRP A 609 1 12 HELIX 12 AB3 GLY A 618 LEU A 626 1 9 SHEET 1 AA1 3 LEU A 370 LEU A 372 0 SHEET 2 AA1 3 GLY A 383 GLN A 391 -1 O TYR A 389 N THR A 371 SHEET 3 AA1 3 GLY A 378 GLY A 380 -1 N GLY A 380 O GLY A 383 SHEET 1 AA2 5 LEU A 370 LEU A 372 0 SHEET 2 AA2 5 GLY A 383 GLN A 391 -1 O TYR A 389 N THR A 371 SHEET 3 AA2 5 VAL A 396 LEU A 404 -1 O LYS A 397 N TYR A 390 SHEET 4 AA2 5 TRP A 444 GLU A 449 -1 O MET A 448 N ALA A 400 SHEET 5 AA2 5 MET A 435 GLU A 440 -1 N GLY A 437 O VAL A 447 SHEET 1 AA3 3 GLY A 454 PRO A 455 0 SHEET 2 AA3 3 VAL A 500 THR A 504 -1 O LEU A 502 N GLY A 454 SHEET 3 AA3 3 TYR A 507 ILE A 510 -1 O LYS A 509 N LEU A 501 SHEET 1 AA4 2 PHE A 490 VAL A 491 0 SHEET 2 AA4 2 LYS A 517 ALA A 518 -1 O LYS A 517 N VAL A 491 SHEET 1 AA5 2 PTR A 525 LYS A 527 0 SHEET 2 AA5 2 LYS A 548 SER A 550 -1 O PHE A 549 N PTR A 526 LINK C ASN A 524 N PTR A 525 1555 1555 1.33 LINK C PTR A 525 N PTR A 526 1555 1555 1.34 LINK C PTR A 526 N LYS A 527 1555 1555 1.33 SITE 1 AC1 2 ARG A 464 TYR A 568 SITE 1 AC2 18 LEU A 377 GLY A 378 ALA A 400 LYS A 402 SITE 2 AC2 18 GLU A 420 VAL A 433 LEU A 446 MET A 448 SITE 3 AC2 18 GLU A 449 MET A 450 ALA A 451 GLY A 454 SITE 4 AC2 18 PRO A 455 LEU A 501 ASP A 512 HOH A1075 SITE 5 AC2 18 HOH A1077 HOH A1108 CRYST1 39.328 87.214 40.230 90.00 92.39 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025427 0.000000 0.001061 0.00000 SCALE2 0.000000 0.011466 0.000000 0.00000 SCALE3 0.000000 0.000000 0.024879 0.00000